Table of Content

1 Market Overview
1.1 Engineered T Cells Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Engineered T Cells Market Size & Forecast
1.4.1 Global Engineered T Cells Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Engineered T Cells Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Engineered T Cells Market Drivers
1.5.2 Engineered T Cells Market Restraints
1.5.3 Engineered T Cells Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Autolus Limited
2.1.1 Business Overview
2.1.2 Autolus Limited SWOT Analysis
2.1.3 Autolus Limited Engineered T Cells Products and Service Offered
2.1.4 Autolus Limited Engineered T Cells Revenue and Gross Margin
2.2 Bellicum Pharmaceuticals
2.2.1 Business Overview
2.2.2 Bellicum Pharmaceuticals SWOT Analysis
2.2.3 Bellicum Pharmaceuticals Engineered T Cells Products and Service Offered
2.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue and Gross Margin
2.3 Cells Medica
2.3.1 Business Overview
2.3.2 Cells Medica SWOT Analysis
2.3.3 Cells Medica Engineered T Cells Products and Service Offered
2.3.4 Cells Medica Engineered T Cells Revenue and Gross Margin
2.4 Elli Lilly and Company
2.4.1 Business Overview
2.4.2 Elli Lilly and Company SWOT Analysis
2.4.3 Elli Lilly and Company Engineered T Cells Products and Service Offered
2.4.4 Elli Lilly and Company Engineered T Cells Revenue and Gross Margin
2.5 Gilead Sciences
2.5.1 Business Overview
2.5.2 Gilead Sciences SWOT Analysis
2.5.3 Gilead Sciences Engineered T Cells Products and Service Offered
2.5.4 Gilead Sciences Engineered T Cells Revenue and Gross Margin
2.6 Juno Therapeutics
2.6.1 Business Overview
2.6.2 Juno Therapeutics SWOT Analysis
2.6.3 Juno Therapeutics Engineered T Cells Products and Service Offered
2.6.4 Juno Therapeutics Engineered T Cells Revenue and Gross Margin
2.7 Novartis
2.7.1 Business Overview
2.7.2 Novartis SWOT Analysis
2.7.3 Novartis Engineered T Cells Products and Service Offered
2.7.4 Novartis Engineered T Cells Revenue and Gross Margin
2.8 Oxford Biomedica
2.8.1 Business Overview
2.8.2 Oxford Biomedica SWOT Analysis
2.8.3 Oxford Biomedica Engineered T Cells Products and Service Offered
2.8.4 Oxford Biomedica Engineered T Cells Revenue and Gross Margin
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Pfizer SWOT Analysis
2.9.3 Pfizer Engineered T Cells Products and Service Offered
2.9.4 Pfizer Engineered T Cells Revenue and Gross Margin
2.10 Precision Bioscience
2.10.1 Business Overview
2.10.2 Precision Bioscience SWOT Analysis
2.10.3 Precision Bioscience Engineered T Cells Products and Service Offered
2.10.4 Precision Bioscience Engineered T Cells Revenue and Gross Margin
2.11 Redmile Group
2.11.1 Business Overview
2.11.2 Redmile Group SWOT Analysis
2.11.3 Redmile Group Engineered T Cells Products and Service Offered
2.11.4 Redmile Group Engineered T Cells Revenue and Gross Margin
2.12 Seeking Alpha
2.12.1 Business Overview
2.12.2 Seeking Alpha SWOT Analysis
2.12.3 Seeking Alpha Engineered T Cells Products and Service Offered
2.12.4 Seeking Alpha Engineered T Cells Revenue and Gross Margin
2.13 Unum Therapeutics
2.13.1 Business Overview
2.13.2 Unum Therapeutics SWOT Analysis
2.13.3 Unum Therapeutics Engineered T Cells Products and Service Offered
2.13.4 Unum Therapeutics Engineered T Cells Revenue and Gross Margin
3 Global Engineered T Cells Market Competition, by Manufacturer
3.1 Global Engineered T Cells Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Engineered T Cells Players Market Share in 2023
3.2.2 Top 6 Engineered T Cells Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Engineered T Cells Players Head Office, Business Provided
3.4 Engineered T Cells Mergers & Acquisitions
3.5 Engineered T Cells New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Engineered T Cells Revenue in Value by Type (2019-2030)
4.2 Global Engineered T Cells Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Engineered T Cells Revenue by Application (2019-2030)
5.2 Global Engineered T Cells Revenue Share by Application (2019-2030)
6 Global Engineered T Cells Market Analysis by Regions
6.1 Global Engineered T Cells Revenue and Market Share by Regions
6.1.1 Global Engineered T Cells Revenue by Regions (2019-2030)
6.1.2 Global Engineered T Cells Revenue Market Share by Regions (2019-2030)
6.2 North America Engineered T Cells Revenue and Growth (2019-2030)
6.3 Europe Engineered T Cells Revenue and Growth (2019-2030)
6.4 Asia Pacific Engineered T Cells Revenue and Growth (2019-2030)
6.5 South America Engineered T Cells Revenue and Growth (2019-2030)
6.6 Middle East and Africa Engineered T Cells Revenue and Growth (2019-2030)
7 North America Engineered T Cells by Country, by Type, and by Application
7.1 North America Engineered T Cells Revenue by Type (2019-2030)
7.2 North America Engineered T Cells Revenue by Application (2019-2030)
7.3 North America Engineered T Cells Revenue and Market Share by Countries
7.3.1 North America Engineered T Cells Revenue in Value by Country (2019-2030)
7.3.2 United States Engineered T Cells Revenue and Growth (2019-2030)
7.3.3 Canada Engineered T Cells Revenue and Growth (2019-2030)
7.3.4 Mexico Engineered T Cells Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Engineered T Cells by Country, by Type, and by Application
8.1 Europe Engineered T Cells Revenue by Type (2019-2030)
8.2 Europe Engineered T Cells Revenue by Application (2019-2030)
8.3 Europe Engineered T Cells Revenue and Market Share by Countries
8.3.1 Europe Engineered T Cells Revenue in Value by Country (2019-2030)
8.3.2 Germany Engineered T Cells Revenue and Growth (2019-2030)
8.3.3 France Engineered T Cells Revenue and Growth (2019-2030)
8.3.4 United Kingdom Engineered T Cells Revenue and Growth (2019-2030)
8.3.5 Russia Engineered T Cells Revenue and Growth (2019-2030)
8.3.6 Italy Engineered T Cells Revenue and Growth (2019-2030)
8.3.7 Nordic Engineered T Cells Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Engineered T Cells by Country, by Type, and by Application
9.1 Asia Pacific Engineered T Cells Revenue by Type (2019-2030)
9.2 Asia Pacific Engineered T Cells Revenue by Application (2019-2030)
9.3 Asia Pacific Engineered T Cells Revenue and Market Share by Countries
9.3.1 Asia Pacific Engineered T Cells Revenue in Value by Country (2019-2030)
9.3.2 China Engineered T Cells Revenue and Growth (2019-2030)
9.3.3 Japan Engineered T Cells Revenue and Growth (2019-2030)
9.3.4 Korea Engineered T Cells Revenue and Growth (2019-2030)
9.3.5 India Engineered T Cells Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Engineered T Cells Revenue and Growth (2019-2030)
9.3.7 Australia Engineered T Cells Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Engineered T Cells by Country, by Type, and by Application
10.1 South America Engineered T Cells Revenue by Type (2019-2030)
10.2 South America Engineered T Cells Revenue by Application (2019-2030)
10.3 South America Engineered T Cells Revenue and Market Share by Countries
10.3.1 South America Engineered T Cells Revenue in Value by Country (2019-2030)
10.3.2 Brazil Engineered T Cells Revenue and Growth (2019-2030)
10.3.3 Argentina Engineered T Cells Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Engineered T Cells by Country, by Type, and by Application
11.1 Middle East & Africa Engineered T Cells Revenue by Type (2019-2030)
11.2 Middle East & Africa Engineered T Cells Revenue by Application (2019-2030)
11.3 Middle East & Africa Engineered T Cells Revenue and Market Share by Countries
11.3.1 Middle East & Africa Engineered T Cells Revenue in Value by Country (2019-2030)
11.3.2 Turkey Engineered T Cells Revenue and Growth (2019-2030)
11.3.3 Egypt Engineered T Cells Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Engineered T Cells Revenue and Growth (2019-2030)
11.3.5 UAE Engineered T Cells Revenue and Growth (2019-2030)
11.3.6 South Africa Engineered T Cells Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Engineered T Cells Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Engineered T Cells Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer